Why peptide processors get shut down — and how we keep yours open.
Research peptide companies sit in one of the most volatile categories in payment processing. Major processors like Stripe, Square, and PayPal explicitly prohibit peptide sales in their acceptable use policies. Traditional banks classify peptides as a regulated wellness product without FDA approval for human use, which means most retail-focused acquirers won't board the account — and the few that do terminate at the first sign of a chargeback spike.
The result for most peptide retailers: bouncing between processors every six months, frozen funds, sudden terminations, and the constant threat of being placed on the MATCH list (which makes future processing nearly impossible).
Payment Gurus boards peptide accounts the right way. We work with sponsor banks that have an established peptide vertical, we underwrite each business individually, and we set up chargeback mitigation infrastructure before your first transaction posts.